Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Adaptive Study for Safety and Efficacy of Pluripotent Cell Secretome on Muscle Performance in Seniors With Sarcopenic Obesity

NCT06600581 is registered in ClinicalTrials.gov with Immunis, Inc. as lead sponsor.

NCT NCT06600581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06600581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Adaptive Study for Safety and Efficacy of Pluripotent Cell Secretome on Muscle Performance in Seniors With Sarcopenic Obesity
Lead sponsor
Immunis, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 19, 2024
Completion date
December 15, 2026
Enrollment
55 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

muscle performance, sarcopenic obesity